AwardTape · Defense awards · Research and development · Health R&D · W81XWH19C0071
W81XWH19C0071: $1.7M definitive contract to Abbott Laboratories Inc
Abbott Laboratories Inc holds a definitive contract from Defense Health Agency with $1.7M obligated since Oct 2023 and $37.6M obligated over its life, against a ceiling of $48.4M. Latest action Apr 9, 2026.
Laboratory assay for traumatic brain injury
| PIID | W81XWH19C0071 |
|---|---|
| Type | definitive contract |
| Company | Abbott Laboratories Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $1.7M |
| Total obligated (lifetime) | $37.6M |
| Ceiling (base and all options) | $48.4M |
| Base date | Mar 1, 2019 |
| Latest action | Apr 9, 2026 |
| End date | Sep 30, 2027 |
| Actions since Oct 2023 | 9 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | IL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial